Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 6/2020

01-12-2020 | Post-Exposure Prophylaxis | Case Report

HIV transmission by human bite: a case report and review of the literature—implications for post-exposure prophylaxis

Authors: Dirk Schürmann, Christian Hoffmann, Miriam S. Stegemann, Christoph Ruwwe-Glösenkamp, Lutz Gürtler

Published in: Infection | Issue 6/2020

Login to get access

Abstract

We report a case of a probable HIV-1 transmission by human bite. The analyzed data from ten previously reported  suspected or allegedly confirmed HIV transmissions revealed a deep bleeding bite wound as the primary risk factor. A high HIV plasma viral load and bleeding oral lesions are present most of the time during HIV transmission by bite. HIV post-exposure prophylaxis (PEP) should be recommended in case of a bleeding wound resulting from a bite of an HIV-infected person. PEP was missed in this presented case.
Literature
1.
Patil PD, Panchabhai TS, Galwankar SC. Managing human bites. J Emerg Trauma Shock. 2009;2:186–90.CrossRef
2.
Cresswell FV, Ellis J, Hartley J, Sabin CA, Orkin C, Churchill DR. A systemic review of risk of HIV transmission through biting spitting: implications for policy. HIV Med. 2018;19:532–40.CrossRef
3.
Rawson JMO, Landman SR, Reilly C, Mansky LM. HIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation. Retrovirology. 2015;12:60.CrossRef
4.
daGuarda Reis MN, Bello G, Guimaraës ML, Stefani MMA. Characterization of HIV-1 CRF90_BF1 and putative novel CRFs_BF1 in Central-West, North and Northeast Brazilian regions. PLoS One. 2017;12:e0178578.CrossRef
5.
Cuevas JM, Geller R, Raquel G, Aldeguer JL, Sanjuan R. Extremely high mutation rate of HIV-1 in vivo. PLoS Biol. 2015;13:e1002251.CrossRef
6.
Wahn V, Kramer HH, Voit T, Brüster HT, Scrampical B, Scheid A. Horiziontal transmission of HIV infection between two siblings. Lancet. 1986;2:694.CrossRef
7.
Anonymous. Transmission of HIV by human bite. Lancet 1987;2:522.
8.
Vidmar L, Poljak M, Tomaszic J, Seme K, Lavs I. Transmission of HIV-1by human bite. Lancet. 1996;347:1762–3.CrossRef
9.
Anonymous. To transmit HIV, biter must have blood in the mouth (quotation from Tom Liberti, Centers for Disease Control and Florida Department of Health). AIDS Policy Law. 1996;11:5.
10.
Liberti T, Lieb S, Scott R, Nolan J, Malecki J, Kalish M, Jaffe H. Blood-to-blood transmission of HIV via bite. In: Program and abstracts of the XI international conference on AIDS; July 7–12, Vancouver, British Columbia. Abstract Mo.D.1728; 1996.
11.
Khajotia RR, Lee E. Transmission of human immunodeficiency virus through saliva after a lip bite. Arch Intern Med. 1997;157:1901.CrossRef
12.
Andreo SMS, Barra LAC, Costa LJ, Sucupira MCA, Souza IE, Diaz RS. HIV type 1 transmission by human bite. AIDS Res Hum Retrovir. 2004;20:349–50.CrossRef
13.
Bartholomew CF, Jones AM. Human bites: a rare risk factor for HIV transmission. AIDS. 2006;4:631–2.CrossRef
14.
Uzoigwe SA, Akani CI, Ariweriokuma B. Human bite and human immune deficiency virus (HIV) transmission. P H Med J. 2007;2:88–9.
15.
16.
Deshpande AK, Jadhav SK, Bandivdekar AH. Possible transmission of HIV infection due to human bite. AIDS Res Ther. 2011;8:16.CrossRef
17.
Jadhav S. Possible transmission of HIV infection due to human bite. Int J Infect Dis. 2018;73(Supplement):247.CrossRef
18.
Thomas MG, Hopkins CJ, Luey CE. Transmission of HIV infection bei severe bites. Int J STD AIDS. 2019;30:927–9.CrossRef
19.
Filippone C, de Oliveira FC, Betsem E, Schaeffer L, Fontanet A, Lemée V, Gessain A, Plantier JC. Simian Immunodeficiency Virus seroreactivity in inhabitants from rural Cameroon frequently in contact with non-human primates. Virology. 2017;503:76–82.CrossRef
20.
Shepard RN, Schock J, Robertson K, Shugars DC, Dyer J, Vernezza P, Hall C, Cohen MS, Fiscus SA. Quantification of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol. 2000;38:1414–8.CrossRef
21.
Shugars DC, Patton LL, Freel SA, Gray LR, Vollmer RT, Eron JJ, Fiscus SA. Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva. J Dent Res. 2001;80:414–20.CrossRef
22.
Baron S, Poast J, Cloyd MW. Why is HIV rarely transmitted by oral secretions. Saliva can disrupt orally shed, infected leucocytes. Arch Intern Med. 1999;159:303–10.CrossRef
23.
Fätkenheuer G, Jessen H, Stoehr A, Jung N, Jessen AB, Kümmerle T, Berger M, Bogner JR, Spinner CD, Stephan C, Degen O, Vogelmann R, Spornraft-Ragaller P, Schnaitmann E, Jensen B, Ulmer A, Kittner JM, Härter G, Malfertheimer P, Rockstroh J, Knecht G, Scholten S, Harrer T, Kern WV, Salzberger B, Schürmann D, Ranneberg B. PEPar: a randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis. HIV Med. 2016;17:453–9.CrossRef
Metadata
Title
HIV transmission by human bite: a case report and review of the literature—implications for post-exposure prophylaxis
Authors
Dirk Schürmann
Christian Hoffmann
Miriam S. Stegemann
Christoph Ruwwe-Glösenkamp
Lutz Gürtler
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-020-01477-6

Other articles of this Issue 6/2020

Infection 6/2020 Go to the issue

Case Report

Duration of posaconazole therapy for Aspergillus fumigatus osteomyelitis dictated by serial monitoring of 1,3-beta-D glucan

Original Paper

Risk for infective endocarditis in bacteremia with Gram positive cocci

Brief Report

Confronting hidden COVID-19 burden: a telemedical solution for elective urological outpatient clinics

Review

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems

Original Paper

Renal profile of chronic hepatitis C patients with sofosbuvir-based therapy

Correspondence

No SARS-CoV-2 detection in the German CAPNETZ cohort of community acquired pneumonia before COVID-19 peak in March 2020
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits